NCT00425217View on ClinicalTrials.gov

Rituximab in Membranous Nephropathy

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2007

Conditions

Membranous Nephropathy

Interventions

DRUG

Rituximab

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Collaborators (1)

Genentech, Inc.

All Listed Sponsors

collaborator

Genentech, Inc.

INDUSTRY

lead

Mayo Clinic

OTHER